The Dublin-based digital pathology software firm said that it will use the money for restructuring and commercial expansion in the US and UK.

The teams are developing over-the-counter, synthetic multi-cancer early detection tests to identify more than 30 stage I solid tumors using breath or urine samples.

The test uses mass spectrometry to measure several proteins to assess the likelihood that an individual has the brain amyloid pathology associated with Alzheimer's disease.

At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.

Of the 30 companies in the index, 18 firms saw their share prices increase month over month, while 12 saw their stock prices decline.

During a talk at the Jefferies Healthcare Services Conference this week, CFO Sam Samad said the business has exceeded the company's expectations.

The firms will integrate Fujifilm's picture archiving and communications system (PACS) with the Precidx's platform that is used to reduce image file sizes.

The test is a bead-based multiplexed immunoassay that also utilizes a machine-learning classifier to determine whether a ...

In total, three studies were published in Nature Medicine that together describe methods to provide more precise diagnoses of sepsis and acute illnesses ...

The company has developed a multiplex panel for bacterial and yeasts infections that it plans to submit for FDA clearance in 2027.

Last week, readers were most interested in a story about the FDA rescinding a rule issued more than a year ago covering the oversight of laboratory-developed tests.